Friday, August 20, 2010

The FDA’s New Power - Matthew Herper - The Medicine Show - Forbes

Risk Evaluation and Mitigation Strategies (REMS) were originally developed for drugs that cause birth defects, like Roche’s acne medicine Accutane or Celgene’s cancer pill Thalomid, also known as thalidomide. But now they have become the new hurdle for companies hoping to market medicines.

Posted via email from Jack's posterous

1 comment:

business hosting said...

Thank you for another great article. Where else could anyone get that kind of information in such a perfect way of writing.